In HCC therapeutic framework, two large families of membrane transporters are involved in drug resistance, the efflux ATP-binding cassette (ABC) transporters and the solute carrier (SLC) superfamily uptake transporters. Here, ABCG2 is linked to hepatocellular carcinoma.